Mymetics is poised to become the leader in the development of proprietary vaccines that focus on the mucosal layer to develop protection against infections using an innovative, safe and effective delivery platform called virosomes.
Mymetics currently has five vaccines in development targeting infectious and life threatening diseases: HIV, Malaria, Respiratory Syncytial Virus, Influenza and Herpes Simplex Virus.
Please see our website for more information.
